Current Diabetes Reports

, Volume 6, Issue 5, pp 344–349

Pramlintide: A new tool in diabetes management


DOI: 10.1007/s11892-006-0004-0

Cite this article as:
Want, L.L. & Ratner, R.E. Curr Diab Rep (2006) 6: 344. doi:10.1007/s11892-006-0004-0


The amylin analogue pramlintide acts in concert with insulin to regulate glucose metabolism. It reduces postprandial hyperglycemia by suppressing postprandial glucagon secretion, regulating gastric emptying, and reducing food intake. In clinical use, pramlintide reduces postprandial glycemic excursions and improves A1c without the weight gain and increased risk of hypoglycemia typically seen with intensification of diabetes therapy.

Copyright information

© Current Science Inc. 2006

Authors and Affiliations

  1. 1.Scientific AffairsMedStar Research InstituteHyattsvilleUSA